1. Ammassari, A., Antinori, A., Cozzi-Lepri, A., Trotta, M. P., Nasti, G., Ridolfo, A. L., et al. (2002). Relationship between HAART adherence and adipose tissue alterations. Journal of Acquired Immune Deficiency Syndromes, 31(Suppl 3), S140–S144.
2. Barkan, S. E., Melnick, S. L., Preston-Martin, S., Weber, K., Kalish, L. A., Miotti, P., et al. (1998). The women’s interagency HIV study WIHS collaborative study group. Epidemiology, 9, 117–125.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. (1996). The Third Health and Nutrition Examination Survey reference manuals and reports. Accessed May 27, 2008, from http://www.cdc.gov/nchs/about/major/nhanes/nh3rrm.htm .
4. Dong, K. L., Bausserman, L. L., Flynn, M. M., Dickinson, B. P., Flanigan, T. P., Mileno, M. D., et al. (1999). Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). Journal of Acquired Immune Deficiency Syndromes, 21, 107–113.
5. Duran, S., Saves, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P., et al. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy: The role of lipodystrophy. AIDS, 15, 2441–2444.